GLD Partners, LP Acquires Seelos Therapeutics, Inc. Assets, Strengthening GLD’s Growing Life Sciences Portfolio
GLD Partners, LP Acquires Seelos Therapeutics, Inc. Assets, Strengthening GLD's Growing Life Sciences Portfolio GLD Announces Successful Closing of Seelos Assets; Includes Ketamine and Trehalose Programs Advancing into Phase 3 Clinical Trials GlobeNewswire October 21, 2025 LOS ANGELES, Oct. 21, 2025 (GLOBE NEWSWIRE) — GLD Partners, LP, with a growing footprint of investments in life […]